Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
Microvascular Therapeutics has raised $4.0M in total funding. The most recent round was Grant. The last funding was announced in October 2023.
Microvascular Therapeutics's investors include National Institutes of Health, National Cancer Institute, Congressionally Directed Medical Research Programs, National Heart, Lung and Blood Institute.
Microvascular Therapeutics is headquartered in Tucson, United States.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
Microvascular Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Microvascular Therapeutics — Funding & Investors." VCBacked, October 18, 2023, https://www.vcbacked.co/company/microvascular-therapeutics. Accessed October 31, 2026.
VCBacked. (2023). Microvascular Therapeutics — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/microvascular-therapeutics
{{cite web |title=Microvascular Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/microvascular-therapeutics |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated